This interaction results in stabilized STAT3-chromatin interactions and subsequent activation of STAT3 downstream signaling, thereby intensifying the oncogenic activity of the EGFR/STAT3 pathway in glioblastoma. Here, STAT3 is linked to glioblastoma.